This inventor holds 36 USPTO granted patents, primarily in Fungicidal Compounds. Top assignees: Sumitomo Chemical Company, Limited, Sumitomo Pharmaceuticals Company Limited, Biotest Pharma Gbmh. Active years: 1976-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Nishinomiya, JA (1976 - 1977)
- Takarazuka, JA (1976 - 1977)
- Maebashi, JA (1977)
- Hyogo, JA (1977)
- Maebashi, JP (1978)
- Nishinomiya, JP (1979)
- Takarazuka, JP (1979)
- Sonehigashi, JP (1981)
- Ashiya, JP (1983)
- Toyonaka, JP (1979 - 1988)
- Osaka, JP (1986 - 1988)
- Kawanishi, JP (1993 - 2004)
Company Filing History:
29 out of 6,961 
7 out of 174 
1 out of 1 
Years Active: 1976-2004
Areas of Expertise:
Title: Hiroshi Noguchi: Innovator in Neurotrophic Therapeutics
Introduction
Hiroshi Noguchi, based in Toyonaka, Japan, is a distinguished inventor with an impressive portfolio of 36 patents. His work focuses primarily on innovative therapeutic agents for treating neurodegenerative diseases and diabetes mellitus, showcasing his commitment to advancing medical science.
Latest Patents
Among his most notable patents are two groundbreaking inventions addressing diabetes treatment. The first patent revolves around a modified form of Brain-Derived Neurotrophic Factor (BDNF), which includes a 1-acyl-glycerol derivative. This modification enhances the pharmacological activities, pharmacokinetics, and physical properties of BDNF, making it a promising therapy for neurodegenerative diseases and type 2 diabetes mellitus.
His second patent pertains to a therapeutic agent combining various neurotrophic factors, including BDNF, for the treatment of diabetes and hyperlipidemia. This innovative agent demonstrates blood glucose-regulating effects, in addition to body fat accumulation and blood lipid regulation, presenting a novel approach to managing type II diabetes without conventional oral hypoglycemics.
Career Highlights
Hiroshi Noguchi has made significant contributions to the field of biotechnology while collaborating with reputable organizations in the industry. Notable companies he has worked with include Sumitomo Chemical Company, Limited, and Sumitomo Pharmaceuticals Company Limited. His expertise has led to the development of therapeutic solutions that pave the way for improved patient outcomes.
Collaborations
Throughout his career, Noguchi has collaborated with esteemed colleagues, including Katsuzo Kamoshita and Toshiro Kato. These partnerships have facilitated the exchange of ideas and expertise, amplifying the impact of his innovative work in the realm of neurotrophic factors.
Conclusion
Hiroshi Noguchi stands out as a prolific inventor whose innovations in neurotrophic therapeutics are poised to revolutionize treatments for diabetes and neurodegenerative diseases. With a robust patent portfolio and impactful collaborations, he continues to contribute significantly to the advancement of medical science, offering hope for better health solutions worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile